SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Regulatory, clinical, and post-marketing challenges of lecanemab for Alzheimer's disease: insights from real-world data.
Giuseppe Marano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it